Use of elevated baseline IL-8, CCL-2, and TNFα to predict for shorter overall survival (OS) in men with metastatic prostate cancer initiating androgen-deprivation therapy (ADT).
Jaya Sharma
No relevant relationships to disclose
Kathryn P. Gray
No relevant relationships to disclose
Mari Nakabayashi
No relevant relationships to disclose
Gillian Petrozziello
No relevant relationships to disclose
Carolyn Evan
No relevant relationships to disclose
Raina Fichorova
No relevant relationships to disclose
Philip W. Kantoff
No relevant relationships to disclose
Christopher Sweeney
No relevant relationships to disclose